baber/WOPTO huggingface dataset:
Patent AU-3629889-A (AU)
Title: Ab-011 antibiotics and process for producing them
Inventor: ANDRIOLLO NUNZIO
IPC: A61K35/74
Filed: 1989-06-13
Abstract: The AB-011 antibiotics and the main components thereof, AB-011a and AB-011b, obtained by means of the controlled aerobic cultivation of Streptomyces s.p. NCIB 12629 in an aqueous nutrient cultivation medium, are disclosed. Said antibiotics show biological activity, in particular antifungal activity.
Patent AU-3648500-A (AU)
Title: Separation of plasma components
Inventor: GILBERT ANDREW MARK
IPC: C07K1/26
Filed: 2000-04-12
Abstract: A method for separating components from plasma, the method comprising (I) separating the plasma into a first and second component, the first component comprising an albumin/alpha-1-antirypsin pool and the second component comprising plasma containing components having a molecular mass greater than albumin; (II) treating the second component to form an immunoglobulins concentrate containing immunoglobulins substantially free from components having a molecular mass less than immunoglobulins; (III) treating the immunoglobulins concentrate to remove components having a molecular mass greater than immunoglobulins; and (IV) separating albumin and alpha-1-antitrypsin from the albumin/alpha-1-antitrypsin pool.
Patent AU-3852189-A (AU)
Title: Subsaturated transdermal delivery device
Inventor: OSBORNE JAMES L
IPC: A61L15/44
Filed: 1989-06-13
Abstract: Subsaturated, rate controlled delivery devices (1) for delivering an agent (5). The initial equilibrated concentration of the agent in the agent reservoir (3) and the adhesive (5) is below saturation. The initial loading of the agent in reservoir (3) is sufficient to prevent the activity of the agent in the reservoir (3) from decreasing by more than about 75 % and preferably no more than about 25 % during the predetermined period of administration. The thicknesses of the adhesive (5), rate controlling membrane (4) and reservoir (3) layers are selected so that at least 50 % and, preferably at least 75 % of the initial equilibrated agent loading is in the reservoir layer (3). The devices (1) are usable to deliver agents which are liquid at body temperatures such as benzotropine, secoverine, nicotine, arecoline, polyethylene glycol monolaurate, glycerol monolaurate, glycerol monooleate and ethanol, for example.
Patent AU-3860397-A (AU)
Title: Manufacture of a metal bonded abrasive product
Inventor: PETERS CHRISTOPHER THOMAS
IPC: C22C26/00
Filed: 1997-09-01
Abstract: A method of manufacturing a metal bonded abrasive product such as a saw or drill segment or bead for a diamond wire is provided. The method includes the steps of providing a mixture of the metal, in particulate form, and the abrasive particles, cold pressing the mixture to the desired final shape at a pressure in the range 320 to 1500 MPa to produce a cold pressed product at a temperature in the range 900 to 1300 DEG  C. under conditions which inhibit degradation of the abrasive particles and the particulate metal. The product, after free sintering, will generally have a relatively high porosity, for example, a porosity of 10 to 25 percent by volume.
Patent AU-3988793-A (AU)
Title: 2,3 (1H,4H)-quinoxalinediones
Inventor: LUBISCH WILFRED
IPC: C07D241/52
Filed: 1993-05-28
Abstract: Quinoxaline-2,3-(1H,4H)diones of the general formula I <IMAGE>  in which the variables have the following meaning:   R<1> is hydrogen; an aliphatic radical having up to 12 C atoms, which can carry one of the following substituents: phenyl, cyclopentyl, cyclohexyl or a group -CO-R<3>, -CO-O-R<3> or -CO-NH-R<3>, where R<3> denotes hydrogen, C1-C4-alkyl, phenyl, benzyl or 1-phenylethyl; a cycloaliphatic radical having up to 12 C atoms, or a phenyl group, where the cyclic groups contained in R<1> can carry up to three of the following substituents: C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, halogen, nitro, cyano, -CO-O-R<3> and -CO-NH-R<3>; R<2> is a pyrrol-1-yl group which can carry up to two of the following substituents: C1-C4-alkyl, phenyl, phenylsulphonyl, nitro, cyano and one of the groups -CO-O-R<3>, -CO-NH-R<3>, -CH2-O-R<3>, -O-R<3> and -CH=NO-R<3>; R is identical or different radicals from the following: C1-C4-alkyl, C1-C4-alkoxy, trifluoromethyl, trichloromethyl, trifluoromethoxy, trichloromethoxy, fluorine, chlorine, bromine, iodine, nitro, cyano and one of the groups -CO-O-R<3> and -CO-NH-R<3> and a fused benzene ring;   n is 0 to 3.   Quinoxaline-2,3-(1H,4H)diones I' <IMAGE>  in which R<1> has the meaning mentioned. The compounds I and I' are suitable as medicines for human and veterinary medicine.
Patent AU-4024797-A (AU)
Title: Use of arachidonic acid and/or docosahexanoic acid for the manufacture of a medicament for the treatment of dyspraxia
Inventor: HORROBIN DAVID FREDERICK
IPC: A61P25/00
Filed: 1997-08-26
Abstract: This invention relates to the administration of arachidonic acid or docosahexaenoic acid or precursors thereof to children or pregnant women for the treatment or prevention of dyspraxia.
Patent AU-4209097-A (AU)
Title: Breast carcinoma-associated gene
Inventor: WEIDLE ULRICH
IPC: C07K14/47
Filed: 1997-09-02
Abstract: A pharmaceutical composition is disclosed, as well as its use in tumour diagnosis, therapy and prevention, methods for diagnosing, treating and preventing tumours, and antibodies and their use.
Patent AU-4247197-A (AU)
Title: Angiogenic factor and use thereof in treating cardiovascular disease
Inventor: NEUFELD GERA
IPC: A61K35/12
Filed: 1997-09-04
Abstract: The present invention relates to novel VEGF protein products, and nucleic acids encoding these novel protein products, comprising exons 1-6 and 8 of the VEGF gene, and derivatives thereof, and these uses in treating the cardiovascular system and its diseases through effects on anatomy, conduit function, and permeability. VEGF145 and its derivatives have been found to be active mitogens for vascular endothelial cells and to function as angiogenic factors in-vivo. VEGF145 and its derivatives have novel properties compared with previously characterized VEGF species with respect to cellular distribution, susceptibility to oxidative damage, and extra-cellular matrix (ECM) binding ability. The present invention also relates to derivatives of VEGF145 which have altered properties in that they have altered biological activity and altered heparin-binding activity when compared to VEGF145. The present invention provides methods of treating the cardiovascular system, enhancing endothelialization of diseased vessels, and enhancing drug permeation by providing the novel VEGF protein products. The invention also provides expression vectors, compositions, and kits for use in the methods of the invention.
Patent AU-4273993-A (AU)
Title: Injection device
Inventor: HJERTMAN BIRGER
IPC: F26B5/06
Filed: 1993-04-16
Abstract: PCT No. PCT/SE93/00336 Sec. 371 Date Nov. 24, 1993 Sec. 102(e) Date Nov. 24, 1993 PCT Filed Apr. 16, 1993 PCT Pub. No. WO93/20869 PCT Pub. Date Oct. 28, 1993.A device for an injection apparatus, including a dual-chamber injection cartridge. The cartridge includes a front end, a rear end, a front opening in the vicinity of a front end of the cartridge, a front chamber located in the vicinity of the front opening and including a drug freeze-dried in the front chamber, a rear chamber including a liquid component, a movable wall separating the front chamber and the rear chamber, a bypass for transferring the liquid component between the front chamber and the rear chamber, and a rear piston. The cartridge is slidably arranged within a cylindrical sleeve substantially the same length as the cartridge. A stopper is located in the vicinity of the front opening of the cartridge. The stopper is directed rearwardly coaxially with the cartridge, wherein as the sleeve is displaced rearwardly after the freeze-drying of the drug, the stopper enters the front opening of the cartridge to sealingly close the cartridge. An actuator for actuating the rear piston may be attached in the vicinity of the rear end of the cartridge.
Patent AU-4294693-A (AU)
Title: Microwave resonator
Inventor: IVANOV EUGENE NIKOLAY
IPC: H01P1/30
Filed: 1993-06-01
Abstract: A dielectrically loaded cavity resonator operable at or near ambient temperatures. The resonator has a desired operating frequency and is dimensioned to operate at a moderate azimuthal mode at this desired operating frequency. The resonator has a dielectric disposed within a cavity dimensioned relative to the dielectric and coupled to provide a Q-factor proximate or substantially commensurate to the maximum possible Q-factor of the resonator for the desired port coupling at the azimuthal mode <IMAGE>
Patent AU-4382796-A (AU)
Title: Plate heat exchanger with wetting device
Inventor: BACHOFEN FRIEDRICH
IPC: F24F1/0059
Filed: 1996-01-16
Abstract: PCT No. PCT/CH96/00019 Sec. 371 Date Jun. 25, 1997 Sec. 102(e) Date Jun. 25, 1997 PCT Filed Jan. 16, 1996 PCT Pub. No. WO96/22497 PCT Pub. Date Jul. 25, 1996The invention relates to a process and device for cooling and cleaning surface elements of a plate heat exchanger to recover heat from outgoing air by spraying water into a stream of outgoing air. Wetting nozzles are used to spray a fine stream of processed water into the outgoing airflow channels of the plate heat exchanger at equal time intervals. This entails no trickling off of sprayed water and the surface elements swept by outgoing air remain moist until the next spraying. Scouring nozzles are used at the end of a daily cooling period to spray a stream of tap water into the outgoing airflow channels. The wetting device comprises a back-and-forth nozzle rail with wetting and scouring nozzles, the axes of which are preferably located in one plane.
Patent AU-4391385-A (AU)
Title: Nickel catalyst supported on alumina
IPC: B01J35/10
Filed: 1985-06-21
Abstract: The invention provides a nickel/alumina/silicate catalyst, with an atomic ratio of nickel/aluminium between 20 and 2, a nickel/silicate ratio between 20 and 1, an active nickel surface area between 70 and 150 m<sup>2</sup>/g nickel and an average pore size, depending on the above atomic ratio, between 4 and 20 nanometers. Preferably the nickel/aluminium atomic ratio is between 10 and 4 and the nickel/silicate ratio between 12 and 3. Preferably the catalyst has a specific porous structure.The invention also provides a method for preparing the catalyst by a two step process involving precipitating nickel ions and adding during a second, so-called ageing step a soluble aluminium compound and optionally the silicate. The silicate is preferably added during a second ageing step.The catalyst is useful for hydrogenating unsaturated organic compounds in particular oils.
Patent AU-4433696-A (AU)
Title: Method of digitally acquiring data on handling operations involving beer barrels
Inventor: KEUPER HARTMUT
IPC: G06K7/08
Filed: 1995-12-22
Abstract: Disclosed is a method of acquiring data on handling operations (filling, emptying, transport and storage) involving barrels (10) used for storing beer or the like. In the proposed process, a transponder (14) fitted in or on the barrel (10) first communicates during filling at a filling point with a transmitter/receiver device (24) allocated to the filling point for the purpose of transmitting data; according to the invention, filling data (relating to filling date, a code describing the liquid, e.g. type of beer, filling quantity, current filling number etc.) is forwarded as or after the barrel (10) is filled from the transmitter/receiver device (24) to the transponder (14) and stored there as a retrievable data set in such a way that the data can be read out or updated to another location at a later time.
Patent AU-4525793-A (AU)
Title: Sequential removal of monosaccharides from the reducing end of oligosaccharides and uses thereof
Inventor: BENDIAK BRAD K
IPC: C07H1/08
Filed: 1993-06-01
Abstract: Methods are provided for the sequential removal of monosaccharides from the reducing end of oligosaccharides. The present invention also discloses the use of such methods for structural determinations of oligosaccharides and to enable new structures to be generated from pre-existing oligosaccharides. In addition, the methods of the present invention may be automated by the incorporation into systems.
Patent AU-4580799-A (AU)
Title: Coagulation controls for pt and aptt assays
Inventor: HAWKINS PAMELA L
IPC: G01N33/96
Filed: 1999-06-21
Abstract: Coagulation control compositions suitable for use in connection with PT and/or APTT assays are disclosed along with their methods of preparation and methods of use. Preferred coagulation controls comprise plasma and an anticoagulant having activity for enhancing the activity of antithrombin III (ATIII) or of heparin co-factor II (HCII) against thrombin or against a clotting factor selected from the group consisting of factors IXa, Xa and XIa. The anticoagulant is preferably a glycosaminoglycan such as heparin, a heparin derivative or a heparin analog. The anticoagulant is preferably combined with (1) an abnormal plasma (e.g. activated plasma or factor-deficient plasma) and/or (2) a primate plasma (e.g. human plasma), and a non-primate mammalian plasma (e.g. bovine plasma). In the latter case, the non-primate mammalian plasma is preferably present in the coagulation control composition in an amount of not more than about 12% by volume, relative to total volume.
Patent AU-4605693-A (AU)
Title: Photoprotection compositions comprising tocopherol sorbate and anti-inflammatory agent
Inventor: BISSETT DONALD LYNN
IPC: A61Q19/08
Filed: 1993-09-01
Abstract: Disclosed are pharmaceutical compositions comprising tocopherol sorbate and an anti-inflammatory agent which are useful for topical application to prevent damage to skin caused by acute or chronic UV exposure. Combinations of tocopherol sorbate, an anti-inflammatory agent, and a sunscreen are also disclosed. Also disclosed is a method for using these compositions topically to prevent damage to skin caused by acute or chronic UV exposure.
Patent AU-4626900-A (AU)
Title: A device for analysing preferably animal manure
Inventor: BERG KAREL VAN DEN
IPC: G01N11/08
Filed: 2000-05-10
Abstract: A device which may be carried by and part of an unmanned vehicle which measures characteristics of manure of animals such as dairy cows that are milked and fed in a stable provided for them. The vehicle is supported by three driven wheels and carries a mechanism for analyzing manure which comprises a compression chamber for receiving a manure sample. A sieve is provided on one side of the chamber and a piston forces the manure sample through the sieve. By measuring the pressure required to squeeze the manure sample through the sieve, characteristics such as the fibrousness and the viscosity of the manure sample can be determined. The vehicle also carries an identification instrumentality for identifying the animal that provided the manure sample and may carry a temperature sensor and an inertia meter. It is operatively associated with a computer which registers data provided from analysis of each animal's manure sample and provides same as displayable data.
Patent AU-4747300-A (AU)
Title: Method for renewing railway lines
Inventor: KNAPE STEFFEN
IPC: E01B37/00
Filed: 2000-04-12
Abstract: The invention relates to a method for renewing railway lines having a substructure (5), a bed (4) consisting of ballast and a track (3) that is mounted thereon and consists of rails (1) and sleepers (2). The inventive method comprises the following steps: removing the existing superstructure (4) that is associated with the track and laying the track (3) on the substructure (5), removing the existing substructure (5, 6) in relation to the track to the depth that is required for the construction of the new railway line, if necessary and laying the track (3) on the resulting base (6), optionally embedding the substructure (9) required for the track, for the new railway line, embedding at least one support layer (8), especially a free or hydraulic support layer, for a solid railway, retreating the existing track (3), producing the solid railway with a track (3) which is mounted on a concrete or asphalt support layer (7) or with a track (3) with sleepers (2) which are cast into a concrete layer, whereby a new track (3) is projected and adjusted.
Patent AU-4758099-A (AU)
Title: Device for converting pictures or images into electronic signals
Inventor: WOLF JOSEF
IPC: H04N5/225
Filed: 1999-09-14
Abstract: The arrangement has a camera (14) with a first objective lens (1) for acquiring images on a projection surface (10). There is a light source (16) with a second objective (3) for focusing the light beams onto the projection surface. Either of objective lenses, especially the first, may be a motor-adjusted zoom lens. At least one pivotable mirror (21,22) is arranged between the projection surface and objectives, to deflect the beam paths associated with the camera and light source.
Patent AU-4781290-A (AU)
Title: Compositions and method for treating or preventing infections in animals
Inventor: BOONE THOMAS C
IPC: A61P31/04
Filed: 1990-01-09
Abstract: Compositions and method for treating or preventing bacterial infections such as mastitis in animals, particularly bovine animals, which comprises administering an effective amount of granulocyte colony stimulating factor (G-CSF), are disclosed. The G-CSF may be naturally derived, or alternatively, the G-CSF and genetically engineered variants of G-CSF may be the expression products of genetically engineered prokaryotic or eukaryotic host cells.
Patent AU-5043599-A (AU)
Title: Myotilin, an actin-organizing protein
Inventor: CARPEN OLLI
IPC: A61K38/00
Filed: 1999-07-14
Abstract: The present invention concerns a novel cytoskeletal protein, myotilin, which contains Ig-like domains homologous to a giant sarcomeric structural protein titin. Myotilin is expressed in skeletal and cardiac muscles, it colocalizes with alpha-actinin in the sarcomeric I-bands and directly interacts with alpha-actinin. Expression of myotilin in mammalian non-muscle cells and in yeast causes reorganization of actin into thick F-actin bundles and inhibits growth of yeast cells.
Patent AU-5243000-A (AU)
Title: Neonatal airway adaptor
Inventor: COLMAN LEWIS
IPC: A61M16/08
Filed: 2000-06-07
Abstract: This invention is a neonatal airway adapter (10) with a sliding internal passage (54), which virtually eliminates void volumes (112) within the bore (76) of the airways, such that mixing of the exhales pages with void gases is reduced, and the waveform of the breath is maintained without undue distortion. Furthermore, the virtual elimination of void volumes reduces the level of re-breathing. The neonatal airway adapter connects to endotracheal tube adapters is such a way as to nullify the effect of the differing internal diameters (20) and internal lengths which are used in ET adapters currently available. The cross section of the internal bore of the airway through which the breath flows from the ET adapter to the connector of the ventilator is maintained almost constant, especially in the region of the gas sampling point (66), to ensure that reasonable conditions of laminar flow, and accurate sampling are maintained.
Patent AU-5422396-A (AU)
Title: Method for treatment of autoimmune diseases using interferon-tau
Inventor: SOOS JEANNE M
IPC: A61K35/12
Filed: 1996-03-15
Abstract: Methods of treating autoimmune disorders, such as multiple sclerosis, are disclosed. The methods employ administration of interferon-tau (IFN tau ) in a therapeutically-effective dose.
Patent AU-5488994-A (AU)
Title: 2-(4-(4-Azolylbutyl)-1-Piperazinyl)-5-hydroxy-pyrimidine derivatives, their preparation and their application as medicinal products
Inventor: CONSTANSA JORDI FRIGOLA
IPC: A61P25/00
Filed: 1994-02-04
Abstract: 2-[4-(4-Azolylbutyl)-1-piperazinyl]pyrimidine derivatives, characterized in that they correspond to the general formula I <IMAGE> in which X2 represents a nitrogen atom or a C-R2 group, X4 represents a nitrogen atom or a C-R4 group and X5 represents a nitrogen atom or a C-R5 group, their process of preparation, their application as medicament and the pharmaceutical compositions comprising them.
Patent AU-5906196-A (AU)
Title: Rotary positive-displacement fluid machine
Inventor: DRIVER RONALD WILLIAM
IPC: F01C21/10
Filed: 1996-06-05
Abstract: A rotary machine has a rotor (450) eccentrically mounted in a casing and having a plurality of vanes (206) connected to oscillating arms (209) via cranks (208), the cranks having elements (400, 401) pivotally embracing a radial outer end of arm (209). The arms (209) can be radial. The rotor (450) has outer parts (457, 458) connected to intermediate part (450) by grooves (453) and rings (452) resisting radial expansion. The rotary machine can be used in a fuel-injected engine for example to derive energy from the difference in air pressure between ambient and the inlet manifold. <IMAGE>
Patent AU-6192780-A (AU)
Title: Surgical staples
Inventor: GREEN D T
IPC: A61B17/10
Filed: 1980-09-01
Abstract: A surgical stapling instrument has upper and lower elongate jaws for receiving a staple cartridge and an anvil respectively. A pusher bar and knife assembly including a pair of pusher bars and a central knife carrier moves longitudinally relative to the jaws to eject staples sequentially from the magazine and form laterally spaced staple rows in tissue gripped between the jaws while the knife cuts the tissue along a line between the staple rows. The instrument includes means for locally supporting the jaws in the region of the pusher bar cams and knife blade as these elements move along the jaws to resist forces created during staple ejection and shaping which tend to vertically separate and/or laterally distort the jaws.
Patent AU-6236294-A (AU)
Title: Elongate plastic member assembly and method and apparatus for making the same
Inventor: MUNSCH JOHN M
IPC: B29C65/48
Filed: 1994-02-04
Abstract: A method of making a peelable tube assembly (76,80,84,88) having a plurality of adjacent tube portions (62) joined by intermittent breakable webs (72) of plastic allowing the individual portions (62) to be peeled from the tube assembly, including providing a plurality of plastic tube portions (62) each having a tube wall (66) defining a flow passage (70). The tube portions (62) are aligned adjacent to one another in a die assembly (12) having compression channels (30). Narrow confined flow chambers (32) are defined between adjacent portions (62) of the tube walls (66), and between the ends of the tube walls (66). The tube portions (62) are radially compressed without occluding the flow passage (70). Small compressed portions of the tube walls (66) proximate the flow chambers (32) are heated and plasticized. The plasticized tube walls portions (66) are flowed into the flow chambers (32) between the adjacent tube portions (62) to fuse the adjacent tube portions ( 62) together with intermittent webs (72) joining the tubular portions (62) until the webs (72) are broken when peeling a tubular portion (62) from the tube assembly (76,80,84,88).
Patent AU-6274598-A (AU)
Title: Expansile device for use in blood vessels and tracts in the body and tension application device for use therewith and method
Inventor: EPSTEIN GORDON H
IPC: A61B17/04
Filed: 1998-02-06
Abstract: A closure device for percutaneously forming a closure of a puncture in the tissue of human body. The device comprises a flexible elongate tubular member having proximal and distal extremities and a longitudinal axis. The flexible elongate tubular member has a first lumen extending from the proximal extremity to the distal extremity. A closure assembly is carried by the distal extremity of the flexible elongate tubular member and is movable between contracted and expanded positions. The closure assembly includes a closure mechanism covered by an impermeable membrane. A handle is carried by the proximal extremity of the flexible elongate tubular member and is adapted to be grasped by the human hand. A deployment mechanism is carried by the handle and extends through the flexible elongate tubular member and is coupled to the closure assembly for moving the closure assembly from the contracted position to the expanded position.